Coronavirus:
News
-
1 June 2020
Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests
South Korea-based Celltrion Group has reported positive results from the preclinical tests of its Covid-19 antibody treatment, which led to a 100-fold decrease in the viral load of SARS-CoV-2.
-
1 June 2020
Russia grants temporary approval for Avifavir to treat Covid-19
The Ministry of Health of the Russian Federation has granted a temporary registration certificate to Covid-19 treatment, Avifavir, produced by the Russian Direct Investment Fund (RDIF) and the ChemRar Group.
-
29 May 2020
Chimeron Bio and NCBID to develop Covid-19 vaccine
RNA therapeutics firm Chimeron Bio has collaborated with George Mason University’s National Center for Biodefense and Infectious Diseases (NCBID) to develop a Covid-19 vaccine candidate.
-
29 May 2020
Novartis’ AveXis agrees to manufacture US researcher Covid-19 vaccine
Novartis unit AveXis has entered into a manufacturing agreement with researchers at Massachusetts Eye and Ear and Massachusetts General Hospital in the US to produce a genetic vaccine against Covid-19,...
-
29 May 2020
GSK plans to produce one billion pandemic vaccine adjuvant doses
GlaxoSmithKline (GSK) is set to produce one billion doses of its pandemic vaccine adjuvant system next year to support adjuvanted Covid-19 vaccine candidates development.
-
28 May 2020
Novavax buys Praha Vaccines for Covid-19 vaccine manufacturing
Biotechnology firm Novavax has acquired Czech Republic-based Praha Vaccines for about $167m to support the manufacture of its Covid-19 vaccine candidate, NVX‑CoV2373.
-
28 May 2020
Israeli scientists say Gaucher’s disease drugs may help treat Covid-19
Scientists from the Israeli Institute for Biological Research (IIBR) have claimed that analogues of two drugs used for the treatment of Gaucher’s disease could be effective against Covid-19.
-
27 May 2020
UK grants early access to Gilead’s remdesivir for Covid-19
The UK Government has announced that some adults and adolescents hospitalised with Covid-19 on the National Health Service (NHS) will have access to Gilead Sciences' remdesivir.
-
27 May 2020
Merck joins race to develop Covid-19 vaccines and drugs
Merck (MSD) has joined the race to develop vaccines and treatments against Covid-19 with three separate agreements with Themis, IAVI and Ridgeback Biotherapeutics.
-
26 May 2020
COVID-19 concerns increase in May following easing of lockdowns
The COVID-19 concern index, as measured by responses to an ongoing poll launched by Verdict in March, has been tracking how the concerns over coronavirus have been changing over time....